...
首页> 外文期刊>Hormones & cancer >Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells
【24h】

Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells

机译:雌激素对激素反应性乳腺癌细胞中microRNA表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Oestrogen receptor alpha (ERα) is a ligand-dependent transcription factor that mediates oestrogen effects in hormone-responsive cells. Following oestrogenic activation, ERα directly regulates the transcription of target genes via DNA binding. MicroRNAs (miRNAs) represent a class of small noncoding RNAs that function as negative regulators of protein-coding gene expression. They are found aberrantly expressed or mutated in cancer, suggesting their crucial role as either oncogenes or tumour suppressor genes. Here, we analysed changes in miRNA expression in response to oestrogen in hormone-responsive breast cancer MCF-7 and ZR-75. 1 cells by microarray-mediated expression profiling. This led to the identification of 172 miRNAs up- or down-regulated by ERα in response to 17β-oestradiol, of which 52 are similarly regulated by the hormone in the two cell models investigated. To identify mechanisms by which ERα exerts its effects on oestrogen-responsive miRNA genes, the oestrogen-dependent miRNA expression profiles were integrated with global in vivo ERα binding site mapping in the genome by ChIP-Seq. In addition, data from miRNA and messenger RNA (mRNA) expression profiles obtained under identical experimental conditions were compared to identify relevant miRNA target transcripts. Results show that miRNAs modulated by ERα represent a novel genomic pathway to impact oestrogen-dependent processes that affect hormone-responsive breast cancer cell behaviour. MiRNome analysis in tumour tissues from breast cancer patients confirmed a strong association between expression of these small RNAs and clinical outcome of the disease, although this appears to involve only marginally the oestrogen-regulated miRNAs identified in this study.
机译:雌激素受体α(ERα)是一种依赖配体的转录因子,可在激素反应性细胞中介导雌激素作用。雌激素激活后,ERα通过DNA结合直接调节靶基因的转录。微小RNA(miRNA)代表一类小的非编码RNA,它们充当蛋白质编码基因表达的负调节剂。发现它们在癌症中异常表达或突变,表明它们作为癌基因或抑癌基因的关键作用。在这里,我们分析了激素反应性乳腺癌MCF-7和ZR-75中响应雌激素的miRNA表达变化。 1个细胞通过微阵列介导的表达谱分析。这导致鉴定了响应17β-雌二醇而被ERα上调或下调的172个miRNA,其中在所研究的两个细胞模型中,有52个类似地受激素调节。为了确定ERα通过其作用于雌激素反应性miRNA基因的机制,将雌激素依赖性miRNA表达谱与ChIP-Seq在基因组中的整体体内ERα结合位点作图整合。另外,比较了在相同实验条件下获得的miRNA和信使RNA(mRNA)表达谱数据,以鉴定相关的miRNA靶转录本。结果表明,由ERα调控的miRNA代表了一种新的基因组途径,可以影响依赖雌激素的过程,从而影响激素反应性乳腺癌细胞的行为。乳腺癌患者肿瘤组织中的MiRNome分析证实了这些小RNA的表达与该疾病的临床结局之间有很强的联系,尽管这似乎只涉及本研究中确定的雌激素调节的miRNA的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号